BIDU-SW
09888
JD HEALTH
06618
ALI HEALTH
00241
JD-SW
09618
NTES-S
09999
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (Q3)Mar 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 38.05%-147.64M | ---- | 44.60%-46.53M | 18.62%-238.31M | ---- | 24.91%-83.99M | -44.24%-292.85M | ---181.17M | -14.10%-111.85M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | ---1.98M | ---- | ---- | ---- | ---- | ---- | 63.09%-306K | ---306K | -22.40%-306K |
Attributable subsidiary (profit) loss | ---- | 3.42%4.93M | ---- | -16.22%1.13M | 14.80%4.76M | ---- | 11.44%1.34M | 6.11%4.15M | --2.34M | 37.05%1.21M |
Asset sale loss (gain): | ---- | 104.06%428K | ---- | 102.08%171K | 49.32%-10.54M | ---- | -1,039.17%-8.2M | -454.97%-20.8M | ---21.16M | -110.35%-720K |
-Available for sale investment sale loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---744K | ---744K | ---- |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | 50.38%-8.53M | ---- | -1,046.77%-8.53M | -445.82%-17.19M | ---17.19M | -112.79%-744K |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1K | -97.89%24K |
-Loss (gain) from selling other assets | ---- | 121.30%428K | ---- | -48.18%171K | 29.83%-2.01M | ---- | --330K | -422.41%-2.86M | ---3.22M | ---- |
Depreciation and amortization: | ---- | -0.93%33.7M | ---- | -0.32%8.74M | -18.67%34.02M | ---- | -32.70%8.77M | -26.83%41.83M | --24.44M | -12.01%13.03M |
-Depreciation | ---- | -0.93%33.7M | ---- | -0.32%8.74M | -18.67%34.02M | ---- | -32.70%8.77M | -26.83%41.83M | --24.44M | -12.01%13.03M |
Financial expense | ---- | -13.15%33.06M | ---- | -32.11%5.9M | 8.45%38.07M | ---- | -11.64%8.69M | -18.66%35.1M | --18.28M | -5.11%9.83M |
Exchange Loss (gain) | ---- | -79.21%2.65M | ---- | -283.73%-1.96M | 845.06%12.73M | ---- | -152.80%-510K | -108.71%-1.71M | --303K | -92.86%966K |
Special items | ---- | -62.33%29.82M | ---- | -87.39%2.87M | -48.44%79.18M | ---- | -51.42%22.75M | 351.06%153.56M | --93.68M | 450.36%46.84M |
Operating profit before the change of operating capital | ---- | 43.78%-45.03M | ---- | 41.96%-29.68M | 1.15%-80.09M | ---- | -24.74%-51.14M | -102.08%-81.02M | ---63.59M | 5.16%-41M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | -97,921.05%-18.62M | ---- | -273.45%-6.17M | 99.92%-19K | ---- | 158.67%3.56M | -283.95%-23.18M | ---2.67M | -170.80%-6.07M |
Special items for working capital changes | ---- | 854.42%43.58M | ---- | 77.63%-19.96M | -76.80%4.57M | ---- | -183.15%-89.25M | 109.44%19.69M | ---69.76M | -46.47%-31.52M |
Cash from business operations | 24.52%-66.73M | 73.43%-20.07M | 40.30%-88.4M | 59.21%-55.82M | 10.62%-75.54M | -8.87%-148.08M | -74.12%-136.83M | -367.17%-84.52M | ---136.01M | -17.31%-78.59M |
Other taxs | -65.83%-5.71M | -1,304.90%-3.44M | -4,202.50%-3.44M | ---2.18M | -235.62%-245K | -9.59%-80K | ---- | 71.60%-73K | ---73K | 46.67%-56K |
Interest received - operating | 656.09%8.13M | 71.21%3.35M | 57.62%1.08M | 40.50%614K | 62.03%1.96M | 16.18%682K | 13.80%437K | 15.03%1.21M | --587K | 35.69%384K |
Net cash from operations | 29.15%-64.31M | 72.70%-20.16M | 38.45%-90.77M | 57.93%-57.38M | 11.46%-73.83M | -8.84%-147.48M | -74.29%-136.4M | -382.04%-83.38M | ---135.5M | -17.13%-78.26M |
Cash flow from investment activities | ||||||||||
Sale of fixed assets | -31.00%69K | 14.80%380K | 14.94%100K | -13.79%75K | 78.92%331K | 20.83%87K | 20.83%87K | -68.21%185K | --72K | --72K |
Purchase of fixed assets | -839.96%-4.35M | 41.89%-4.27M | 89.73%-463K | 96.69%-39K | 60.08%-7.34M | 45.71%-4.51M | 74.25%-1.18M | 82.79%-18.38M | ---8.3M | -94.44%-4.58M |
Sale of subsidiaries | ---- | ---- | ---- | ---- | 91.40%-1.44M | 91.40%-1.44M | ---1.44M | -1,254.42%-16.72M | ---16.72M | ---- |
Recovery of cash from investments | --172.46M | ---- | ---- | ---- | ---- | ---- | ---- | -9.59%33.95M | --33.95M | 3,801.84%33.95M |
Cash on investment | ---174.7M | ---141.68M | ---- | ---- | ---- | ---- | ---- | 96.48%-4.5M | ---4.5M | ---4.5M |
Other items in the investment business | ---- | ---1.03M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from investment operations | -1,695.87%-6.52M | -1,635.90%-146.6M | 93.80%-363K | 101.42%36K | -54.47%-8.45M | -230.24%-5.86M | -110.14%-2.53M | 97.20%-5.47M | --4.5M | 5,557.11%24.94M |
Net cash before financing | 22.28%-70.83M | -102.68%-166.76M | 40.57%-91.13M | 58.72%-57.35M | 7.40%-82.27M | -17.05%-153.34M | -160.56%-138.93M | 58.18%-88.85M | ---131M | 20.74%-53.32M |
Cash flow from financing activities | ||||||||||
New borrowing | --50M | ---- | ---- | ---- | 12.12%270M | 70,075.44%240M | ---- | 60.54%240.8M | --342K | -99.72%342K |
Refund | -35,500.00%-49.84M | 99.81%-280K | 99.88%-140K | 25.00%-60K | 7.16%-150.17M | -16,599.58%-120.07M | 85.19%-80K | -3.31%-161.75M | ---719K | 99.05%-540K |
Issuing shares | ---- | --567.65M | ---- | ---- | ---- | ---- | ---- | --33.26M | --33.26M | --33.26M |
Interest paid - financing | 4.69%-12.08M | -9.21%-25.16M | -22.71%-12.68M | -29.05%-6.27M | -45.90%-23.04M | -28.69%-10.33M | -21.82%-4.86M | 10.44%-15.79M | ---8.03M | 11.30%-3.99M |
Issuance expenses and redemption of securities expenses | -766.49%-6.59M | -27.89%-2.45M | 46.75%-761K | -160.00%-65K | 53.85%-1.92M | ---1.43M | ---25K | ---4.16M | ---- | ---- |
Other items of the financing business | ---- | -253.91%-7.96M | -882.31%-7.5M | -339.58%-3.35M | -204.47%-2.25M | 81.26%-763K | ---763K | 92.20%-739K | ---4.07M | ---- |
Net cash from financing operations | -1.97%-33.78M | 681.08%504.77M | -136.15%-33.13M | -10.75%-17.39M | -0.42%64.62M | 1,702.22%91.64M | -166.38%-15.71M | -70.00%64.9M | --5.09M | -92.92%23.66M |
Effect of rate | 354.37%3.74M | -426.97%-11.97M | -54.82%824K | -103.23%-504K | 222.41%3.66M | 180.71%1.82M | -132.98%-248K | 88.69%-2.99M | ---2.26M | -90.71%752K |
Net Cash | 15.82%-104.61M | 2,015.20%338.01M | -101.42%-124.26M | 51.66%-74.74M | 26.32%-17.65M | 51.00%-61.69M | -421.38%-154.63M | -725.43%-23.95M | ---125.92M | -111.12%-29.66M |
Begining period cash | 92.96%676.79M | -3.84%350.75M | -3.84%350.75M | -3.84%350.75M | -6.88%364.74M | -6.88%364.74M | -6.88%364.74M | -5.46%391.68M | --391.68M | -5.46%391.68M |
Cash at the end | 153.37%575.93M | 92.96%676.79M | -25.44%227.31M | 31.28%275.5M | -3.84%350.75M | 15.70%304.87M | -42.15%209.86M | -6.88%364.74M | --263.51M | -47.36%362.78M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | PricewaterhouseCoopers | -- | -- | PricewaterhouseCoopers | -- | -- | PricewaterhouseCoopers | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.